Novo Holdings board member steps down after less than two years in role

Carsten Stendevad has chosen to leave Novo Holdings' board as he has been given new investment responsibilities at the world's largest hedge fund, Bridgewater.

Carsten Stendevad | Photo: PR/ Bridgewater Associates

After just under two years in the role of board member at Novo Nordisk fund Novo Holdings, Carsten Stendevad has chosen to step down.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs